Dendritic cell-based immunotherapy of renal cell carcinoma

Urologia Internationalis

Volumn 61, Issue 2, 1998, Pages 67-71

  Thurnher, Martin ^a   Rieser, Claudia ^a   Höltl, Lorenz ^a   Papesh, Christine ^a   Ramoner, Reinhold ^a   Bartsch, Georg ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

KEYHOLE LIMPET HEMOCYANIN; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN BINDING; CELL ACTIVATION; CELL LYSATE; CELL MATURATION; DENDRITIC CELL; HUMAN; IMMUNOTHERAPY; KIDNEY CARCINOMA; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; CARCINOMA, RENAL CELL; CELLS, CULTURED; DENDRITIC CELLS; HUMANS; IMMUNITY, CELLULAR; IMMUNOTHERAPY; INFUSIONS, INTRAVENOUS; KIDNEY NEOPLASMS; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0032432339     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030291     Document Type: Short Survey

References (18)

1. Banchereau J, Steinman RM: Dendritic cells and the control of immunity. Nature 1998;392: 245-252.
2. Pierre P, Mellman I: Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998;93:1135-1145.
3. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A: Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388:782-787.
4. Thurnher M, Ramoner R, Gastl G, Radmayr C, Böck G, Herold M, Klocker H, Bartsch G: Bacillus Calmette-Guérin mycobacteria stimulate human blood dendritic cells. Int J Cancer 1997;70:128-134.
5. Ramoner R, Rieser C, Herold M, Klocker H, Bartsch G, Stenzl A, Thurnher M: Activation of human dendritic cells by bacillus Calmette-Guerin. J Urol 1998;159:1488-1492.
6. Cella M, Scheidegger D, Palmer Lehmann K, Lane P, Lanzavecchia A, Alber G: Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation. J Exp Med 1996;184:747-752.
7. Lanzavecchia A: Licence to kill. Nature 1998;393:413-414.
8. Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taidi B, Engleman EG, Levy R: Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. Nat Med 1996;2:52-58.
9. Murphy G, Tjoa B, Ragde H, Kenny G, Boynton A: Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen. Prostate 1996;29:371-380.
10. Nestle FO, Alijagic S, Gilliet M, Sun Y, Grabbe S, Dummer R, Burg G, Schadendorf D: Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med 1998;4:328-332.
11. Motzer RJ, Bander NH, Nanus DM: Renal-cell carcinoma. N Engl J Med 1996;335:865-875.
12. Radmayr C, Böck G, Hobisch A, Klocker H, Bartsch G, Thurnher M: Dendritic antigen-presenting cells from the peripheral blood of renal cell carcinoma patients. Int J Cancer 1995;63: 627-632.
13. Thurnher M, Radmayr C, Ramoner R, Ebner S, Böck G, Klocker H, Romani N, Bartsch G: Human renal cell carcinoma tissue contains dendritic cells. Int J Cancer 1996;67:1-7.
14. Thurnher M, Papesh C, Ramoner R, Gastl G, Böck G, Radmayr C, Klocker H, Bartsch G: In vitro generation of CD83+ human blood dendritic cells for the active tumor immunotherapy. Exp Hematol 1997;25:232-237.
15. 2 and tumor necrosis factor alpha cooperate to activate human dendritic cells: Synergistic activation of interleukin 12 production. J Exp Med 1997;186: 1603-1608.
16. 2. Blood 1998;91:3112-3117.
17. Höltl L, Rieser C, Papesh C, Ramoner R, Herold M, Klocker H, Radmayr C, Stenzl A, Bartsch G, Thurnher M: Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen-loaded dendritic cells. J Urol 1998, in press.
18. Höltl L, Rieser C, Papesh C, Ramoner R, Bartsch G, Thurnher M: CD83+ blood dendritic cells as a vaccine for the active, specific immunotherapy of renal cell carcinoma. Lancet 1998; in press.